Primary management of advanced lymphosarcoma with radiotherapy

Ralph E. Johnson,G. O'conor,David Levin
DOI: https://doi.org/10.1002/1097-0142(197004)25:4<787::AID-CNCR2820250407>3.0.CO;2-E
IF: 6.9209
1970-04-01
Cancer
Abstract:The results of a pilot study are described using radiotherapy as the primary treatment for patients with advanced lymphosarcoma. Therapy was directed toward the achievement of complete control of disease using total body irradiation (TBI) and total nodal irradiation (TNI). Chemotherapy had restricted use and was reserved for situations where further irradiation appeared to offer limited benefit. All 11 patients with generalized lymph node involvement (Stage III) are currently alive with a median observation of nearly 3 years, and 4 of these have remained continuously free of disease for more than 2 years since initial therapy. Encouraging remission and survival rates have also been observed for patients with generalized lymph node plus bone marrow involvement. In contrast, response to therapy and survival have been very unsatisfactory for patients with extranodal dissemination of disease to sites other than the bone marrow. The clinical staging has correlated better with survival than has the histologic classification based on estimation of tumor cell differentiation. This experience suggests a role for radiotherapy in the primary management of selected patients with advanced lymphosarcoma.
What problem does this paper attempt to address?